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Abstract 
Background: Pseudomonas aeruginosa strains that are classed as extensively drug resistant (XDR-PA) are resistant 
to all antibiotics except for one or two classes and are frequently the cause of hard-to-treat infections worldwide. 
Our study aimed to characterize clinical XDR-PA isolates recovered during 2011–2012 at nine hospitals in the Hunan 
province of China.
Methods: Thirty-seven non-repetitive XDR-PA strains from 37 patients were investigated for genes encoding anti-
microbial resistance determinants, efflux pumps, outer membrane proteins, and movable genetic elements using 
polymerase chain reaction (PCR). The expression of genes encoding the efflux pump component MexA and the outer 
membrane protein OprD was measured using real-time PCR. In addition, clonal relatedness of these XDR-PA isolates 
was analyzed by pulsed-field gel electrophoresis (PFGE).
Results: Various genes encoding antimicrobial resistance determinants were found in all isolates. In particular, the 
blaTEM-1, blaCARB, armA, blaIMP-4, blaVIM-2, and rmtB, were found in 100, 37.8, 22, 22, 19 and 5 % of the isolates, respec-
tively. Remarkably, two isolates coharbored blaIMP-4, blaVIM-2, and armA. In all 37 antibiotic-resistant strains, the relative 
expression of oprD was decreased while mexA was increased compared to the expression of these genes in antibiotic-
susceptible P. aeruginosa strains. All of the XDR-PA isolates harbored class I integrons as well as multiple other mobile 
genetic elements, such as tnpU, tnp513, tnpA (Tn21), and merA. A high genotypic diversity among the strains was 
detected by PFGE.
Conclusions: Multiple antibiotic-resistance mechanisms contributed to the drug resistance of the XDR-PA isolates 
investigated in this study. Thus, the XDR-PA isolates in this area were not clonally related. Instead, multiple types of 
movable genetic elements were coharbored within each XDR-PA isolate, which may have aided the rapid develop-
ment of these XDR-PA strains. This is the first report of XDR-PA strains that coharbor blaIMP-4, blaVIM-2, and armA.
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Background
Pseudomonas aeruginosa, a rod-shaped, non-fermenting 
gram-negative bacterium, causes nosocomial infections 
that can lead to sepsis, pneumonia, endocarditis, and 
urinary tract infections. The emergence of extensively 
drug-resistant P. aeruginosa (XDR-PA) strains showing 
resistant to all antimicrobial agents except for one or two 
classes is becoming a major public health concern [1–5].
That was found by previous studies the mechanisms 
of antibiotic resistance associated with clinical XDR-PA 
isolates are complex [6, 7]. The prevailing hypothesis is 
that XDR-PA isolates acquire numerous drug-resistance 
determinants through horizontal gene transfer that is 
mediated by mobile genetic elements [8–10]. In addi-
tion, genes encoding the antibiotic-inactivating enzymes 
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β-lactamases, aminoglycoside-modifying enzymes 
(AMEs), and 16S rRNA methylases (16S-RMTases) 
are frequently associated with antibiotic resistance in 
XDR-PA strains. In recent studies, an over-expression of 
drug-efflux pumps and diminished expression of outer 
membrane proteins are suggested to play a role in drug 
resistance [11–14].
Although the prevalence of drug-resistance determi-
nants in XDR-PA strains isolated in other countries has 
been determined [15, 16], few studies have investigated 
the resistance mechanisms and the epidemiological pro-
files of clinical XDR-PA isolates found in China. Before 
2011, XDR-PA strains were rarely found in China; there-
after, a gradual emergence has occurred in some hospi-
tals. Therefore, the purpose of this study was to analyze 
the resistance mechanisms and molecular epidemiology 
of clinical XDR-PA strains isolated earlier in our region 
recovered from 2011 to 2012.
Methods
Bacterial isolates
Thirty-seven out of 482 (7.7  %) P. aeruginosa isolates 
that were screened were XDR-PA strains displaying 
resistance to all antimicrobial agents except colistin. 
The P. aeruginosa strains were isolated from September 
1, 2011 to June 30, 2012 from nine of fifteen different 
hospitals in the Hunan province of China. Drug sus-
ceptibility of XDR-PA isolates was determined by the 
Kirby-Bauer (K-B) disk diffusion method and two qual-
ity control strains (Escherichia coli ATCC25922 and P. 
aeruginosa ATCC27853) were included in the analyses. 
The results were analyzed and interpreted according 
to the guidelines of Clinical and Laboratory Standards 
Institute (CLSI) [17]. To prevent analysis of redundant 
strains, only the first strain was collected when dupli-
cate strains were from the same patient.
Phenotypic tests for carbapenemase production
The modified Hodge test (MHT) was used to detect the 
production of carbapenemase using an imipenem disc 
(10 μg) as described by CLSI [17]. A combined-disc test 
was carried out to detect the production of metallo-
β-lactamase (MBL). Two discs [One disc contained 
imipenem (10  μg) and 5  μL of 0.5  M EDTA (Sigma 
Chemicals), and the other disc contained only imipe-
nem (10  μg)] were placed 20  mm apart on a Mueller–
Hinton agar plate inoculated with each test strain. A 
strain was considered positive for metallo-β-lactamase 
production when the zone diameter around the imipe-
nem-EDTA disc was more than 4 mm of the imipenem-
only disc [18].
Detection of genes encoding antimicrobial resistance 
determinants and genes associated with movable genetic 
elements
The DNA templates used in polymerase chain reac-
tions (PCR) to amplify genes encoding antimicrobial 
resistance determinants were obtained as follows: bac-
terial suspensions were incubated for 10 min at 95  °C 
followed by centrifugation at 10,000×g for 10  min to 
remove cellular debris. Genes coding for carbapenem 
β-lactamases (blaKPC, blaSME, blaGES, blaIMI/blaNMC, 
blaNDM-1, blaVIM-2, blaIMP-4, blaSIM-1, blaGIM, blaSPM, 
blaOXA-23, and blaOXA-51), extended-spectrum 
β-lactamases (ESBLs) (blaTEM-1, blaCTX-M, blaSHV, 
blaOXA-1, blaOXA-2, blaOXA-10, blaVEB, and blaPER), and 
AmpC β-lactamases (blaMOX, blaFOX, blaDHA, blaCIT, 
and blaEBC) were performed by PCR with previously 
described primers [18–20]. In addition, the isolates 
were screened by PCR for AME genes (aac(3)-IIa and 
ant(2′’)-Ia) [21], 16S-RMTases (armA, npmA, rmtA, 
rmtB, rmtC, rmtD, and rmtE) [22], a drug-efflux pump 
component (mexA), and an outer membrane protein 
(oprD). The PCR primers used to screen for these 
genes are listed in Table 1. To detect genes associated 
with the movable genetic elements, intI, traA, traF, 
trbC, tnp513, ISpa7, ISEcp1, tnpU, tnpA (Tn21), tnsA, 
and merA, PCR was performed with primers shown in 
Table 1. All amplified DNA fragments were sequenced 
and then analyzed using the BLAST program (http://
www.ncbi.nlm.nih.gov/BLAST).
Quantifying expression of mexA and oprD
The expression of mexA and oprD in the XDR-PA 
isolates was determined by real-time PCR (RT-PCR). 
The experimental group consisted of the 37 XDR-PA 
isolates and the control group was made up of 31 P. 
aeruginosa isolates that were collected at the same 
time as the XDR-PA strains but were shown to be 
sensitive to all antimicrobial agents tested. The prim-
ers used for quantifying mexA and oprD expression 
are listed in Table 1. The RT-PCR reactions were car-
ried out by a QuantiFast SYBR Green RT-PCR Kit 
from Qiagen and a Real-Time PCR System of Light-
Cycler 2.0 from Roche, Burgess Hill, UK, according 
to the manufacturer protocols. All reactions were 
repeated three times using 10  ng of RNA template 
that was prepared using the RNeasy Mini Kit from 
Qiagen, Crawley, UK and treated with Dnase. Gene 
expression was normalized relative to that of the 
16S rRNA gene using the 2−△△CT method [23]. The 
expression of 16S rRNA gene was determined by the 
primers shown in Table 1.
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Pulsed‑field gel electrophoresis (PFGE)
Clonal relatedness of the XDR-PA isolates was analyzed 
by PFGE. Preparation of genomic DNA was done in aga-
rose blocks. The DNA was then digested by the restric-
tion enzyme XbaI from Promega, USA, followed by 
embedding into 1  % PFGE agarose gel. PFGE was per-
formed for 24 h using the GenePath System from Bio-
Rad with the follow conditions: 5.5  V/cm, 12  °C, 120°, 
and a switch time from 4 to 40  s. The molecular size 
marker, Salmonella enterica strain H9812, was obtained 
from the respiratory laboratory of infectious diseases, 
CDC, China. The gel was stained for 30 min with eth-
idium bromide and the gel image was documented 
using the gel documentation system Gel Doc 2000 from 
Bio-Rad. Finally, analyses of the results were performed 
by the BioNumerics software platform (Applied Math, 
Sint-Maten-Latem, Belgium) and visual inspection with 
the criteria of relatedness proposed by Tenover et  al. 
[24].
Statistical analysis
WHONET software (version 5.4, WHO) was used to 
analyze the patient demographic information and the 
antibiotic resistance data using the 2014 CLSI criteria for 
breakpoints for P. aeruginosa. Comparisons of different 
groups were analyzed by a two-sided Chi square (χ2) test 
with the SPSS13.0 software (SPSS Inc., USA). A P < 0.05 
was regarded as statistically significant.
Results
Phenotypic screening and resistance determinants
Of the 37 XDR-PA isolates, 13 (35.1  %) isolates were 
positive for MTH and MBL, while all other isolates were 
negative (Fig. 1).
Diverse types of genes encoding antibiotic-inactivating 
enzymes were detected. Specifically, the genes blaTEM-1, 
blaCARB, armA, blaIMP-4, blaVIM-2, and rmtB were found 
in 100, 37.8, 22, 22, 19 and 5  % of the XDR-PA isolates, 
respectively. The ESBL gene blaTEM-1 was found in all 
Table 1 Primers used in this study for PCR and RT-PCR analyses








































mexA in RT-PCR F:GGCGACAACGCGGCGAAGG
R:CCTTCTGCTTGACGCCTTCCTGC
202
oprD in RT-PCR F:CGGCGACATCAGCAACACC
R:GGGCCGTTGAAGTCGGAGTA
195
16S rRNA in RT-PCR F:CCTACGGGAGGCAGCAG
R:ATTACCGCGGCTGCTGG
194
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isolates, while the other ESBL genes that were tested were 
not found in any of the isolates. Among the 37 XDR-PA 
isolates, 13 (35.1 %) isolates were positive for MBLs genes, 
8 contained blaIMP-4, and 7 contained blaVIM-2. Two types 
of 16S-RMTases genes were detected. Eight isolates con-
tained armA, while two isolates contained rmtB. Eight 
isolates coharbored blaIMP-4 and armA and two isolates 
coharbored blaIMP-4, blaVIM-2, and armA. No isolates har-
bored genes encoding AmpC β-lactamases or AMEs.
The efflux-pump gene mexA and the outer membrane 
protein gene oprD were detected in all 37 XDR-PA iso-
lates. However, no mutations were detected in any of the 
oprD genes. Figure 1 lists the antibiotic resistance genes 
detected in each isolate.
Expression of mexA and oprD
The expression of mexA was significantly higher in the 37 
XDR-PA isolates than in the control group consisting of 31 
antibiotic-sensitive isolates (1.95  ±  0.48 and 0.70  ±  0.13, 
P = 0.018, respectively), while expression of oprD in the XDR-
PA strains was significantly lower than the control group 
(3.18 ± 0.60 and 0.94 ± 0.08; P = 0.002, respectively; Fig. 2).
Distribution of genes associated with movable genetic 
elements
Of the movable genetic element genes tested, intI, merA, 
tnp513, tnpA (Tn21), and tnpU were detected in 100, 100, 
81, 49, and 16  % of the isolates, respectively. Moreover, 
most of the 37 XDR-PA isolates coharbored three or 
more genes associated with movable genetic elements. 
For instance, isolates xy36 coharbored five types of mov-
able genetic element genes (Fig. 1).
Clonal relatedness of the XDR‑PA isolates
Using PFGE, the 37 XDR-PA isolates were divided into 
21 PFGE types (Fig.  1). The main PFGE type found was 
Fig. 1 Clinical features, molecular characterization, and dendrogram based on PFGE of 37 XDR-PA isolates. The dendrogram was developed using 
the BioNumerics software platform. P patients, Ss specimens, RDs resistance determinants, xy Xiangya Hospital, f3 the Third Xiangya Hospital, yy 
People’s Hospital of Liuyang, cs the Third Hospital of Changsha, se the Second People’s Hospital of Hunan province, xt Xiangtan Central Hospital, lz 
Chinese Medicine Hospital of Liuyang, cz People’s Hospital of Chenzhou, cy the First Hospital of Changsha, and A–U PFGE types
Fig. 2 The relative expression of the mexA and oprD genes in the 
XDR-PA isolates. The relative expression levels are expressed as the 
mean ± standard error of the mean (SEM). *P values less than 0.05 are 
considered significant and are indicated by an asterisk
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A (five strains), including three strains from Xiangya Hos-
pital and two strains from the Third Xiangya Hospital. In 
addition, an A1 subtype was found in both hospitals. The 
B- and C-type isolates were found in the Xiangya Hospi-
tal, while the D-type isolates were found in the Third Hos-
pital of Changsha as well as Chinese Medicine Hospital of 
Liuyang. The E-type strains were isolated from the Sec-
ond People’s Hospital of Hunan province and the Third 
Xiangya Hospital, and an E1 subtype was found in both 
hospitals. The F-type strains were isolated from the Peo-
ple’s Hospital of Liuyang; the G-type strains were isolated 
from the Third Xiangya Hospital; and the H-type isolates 
were found at Xiangya Hospital and Xiangtan Central 
Hospital. The remaining 13 types, from I to U, were col-
lected from the Xiangya Hospital (eight strains), the Peo-
ple’s Hospital of Chenzhou (one strain), the First Hospital 
of Changsha (one strain), the Chinese Medicine Hospital 
of Liuyang (one strain), the Third Xiangya Hospital (one 
strain), and the Third Hospital of Changsha (one strain).
Discussion
Pseudomonas aeruginosa is considered one of the pri-
mary causes of hospital-acquired infections. An increase 
in the prevalence of clinical XDR-PA isolates corre-
lates with a rise in mortality and morbidity rates. Con-
sequently, XDR-PA strains pose a considerable threat 
to public health worldwide. In our study, 37 out of 482 
(7.7  %) P. aeruginosa strains were found to be XDR-PA 
strains. The XDR-PA strains were isolated from nine of 
fifteen teaching hospitals detected in our region, suggest-
ing that the occurrence of XDR-PA isolates in our region 
is low. To aid the prevention of the spread of XDR-PA 
strains, we have analyzed the resistance mechanisms and 
the molecular epidemiology of the XDR-PA strains.
Carbapenems are one of the most effective drugs 
against severe infections caused by gram-negative bacilli. 
Unfortunately, pathogens displaying resistance to car-
bapenems are increasing due to the following three main 
causes: production of carbapenemases, the over-expres-
sion of efflux pumps, and the diminished expression of 
the outer membrane porin OprD [15]. In P. aeruginosa, 
production of carbapenemases, especially MBLs, is an 
important antibiotic resistance mechanisms [25]. In this 
study, 13 (35.1 %) strains produced the metallo-enzymes 
IMP-4 and VIM-2, indicating that production of car-
bapenemases played role in carbapenem-resistant in the 
XDR-PA isolates. Notably, the prevalence of carbapene-
mases in the 37 XDR-PA isolates in our study were higher 
than that of other countries in the world [26, 27] and 
from other regions in China [28]. One isolate that cohar-
bored two MBL genes was reported in previous stud-
ies [29]. This observation led to the emergence of a new 
drug-resistant model for P. aeruginosa. In our study, two 
isolates (xy35 and xy36) coharbored blaIMP-4 and blaVIM-2. 
To our knowledge, this is the first report of the co-exist-
ence of blaIMP-4 and blaVIM-2 in a P. aeruginosa strain.
Drug-efflux pumps have been correlated with bacte-
rial resistance since the 1980s [30]. The first efflux pump 
found in P. aeruginosa is the MexAB-OprM pump, which 
has a broad range of substrates, including carbapenems, 
quinolones, aminoglycosides, tetracyclines, and mac-
rolides. Therefore, the presence of this efflux pump in 
bacteria may lead to multi-drug resistance. In our study, 
the mexA gene, encoding a component of MexAB-OprM 
efflux pump, was found in all 37 XDR-PA isolates. Fur-
thermore, a significant over-expression of mexA in the 
XDR-PA isolates was seen compared with the mexA lev-
els in antibiotic-susceptible strains. Thus, over-expres-
sion of an efflux pump, especially MexAB-OprM, may 
play a key role in the antibiotic resistance of these XDR-
PA isolates.
Decreased expression of OprD can significantly reduce 
the susceptibility of P. aeruginosa to carbapenems. Previ-
ous studies showed that decreased expression of oprD is 
primarily due to mutations in the OprD-encoding genes 
[31]. In our study, the expression of oprD in the 37 XDR-
PA isolates was significantly lower than that in suscepti-
ble strains confirming that a decreased level of this porin 
plays a key role in carbapenem-resistance. However, no 
mutations or deletions were detected for the oprD gene 
in the 37 XDR-PA isolates. This finding was not con-
sistent with previous studies [32, 33], suggesting that 
decreased expression of oprD in the 37 XDR-PA isolates 
might be due to regulation by small bioactive molecules, 
amino acids, or efflux pump expression [34]. Therefore, 
in-depth studies on the role of outer membrane proteins 
in bacterial drug resistance are needed in the future.
Production of AMEs and 16S-RMTases is the main 
cause of bacterial resistance to aminoglycoside agents 
[35, 36]. In contrast to these reports, none of the 37 XDR-
PA isolates, which were resistant to aminoglycoside anti-
biotics, harbored genes encoding AMEs and only 27.0 % 
(n  =  10) harbored either armA or rmtB 16S-RMTases 
genes. These data suggest that 16S-RMTases play an 
important role in aminoglycoside resistance in the XDR-
PA isolates but also that some of these isolates may uti-
lize an alternative, unknown resistance mechanism, such 
as new drug efflux pumps, new 16S-RMTases, or muta-
tional activation of the AmgRS two-component system 
[37].
Movable genetic elements, including integrons, plas-
mids, transposons, and insertion sequences, play a key 
role in the horizontal transfer of resistance genes [38]. In 
this study, most of the XDR-PA isolates coharbored three 
or more genes associated with movable genetic elements. 
The most frequently detected genes were intI, merA 
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tnp513, tnpA (Tn21), and tnpU, and their distribution 
percentage among the XDR-PA isolates was 100, 100, 
81, 49, and 16 %, respectively. Furthermore, two isolates, 
cs15 and xy36, coharbored 5 types of genes associated 
with movable genetic elements.
The XDR-PA strains previously isolated in other coun-
tries were shown to be clonally related [1]. In contrast, the 
XDR-PA strains isolated from hospitals within the Hunan 
province of China were shown to be genetically diverse. 
The 37 XDR-PA isolates were divided into 21 different 
PFGE types and no one type predominated amongst the 
isolates suggesting that none of the XDR-PA isolates are 
considered to be an epidemic clone. Interestingly, the 
A-type, D-type, E-type, and H-type were detected in two 
different hospitals and the B-type, C-type, and F-type 
were found in two different wards of the same hospital 
during the same time period. Although prevalence of the 
XDR-PA isolates in this area was sporadic, dissemination 
of the same isolate was detected inter- and intra-hospital. 
The high heterogeneity of the PFGE types suggests that 
the mobile genetic elements may play a role in the emer-
gence of clinical XDR-PA strains.
Conclusions
In conclusion, this study shows that the extreme antibi-
otic resistance of the clinical XDR-PA isolates is due to 
strains coharboring multiple antibiotic resistance genes, 
over-expressing drug-efflux pumps, and decreasing 
expression of oprD, which encodes an outer membrane 
porin. Moreover, this study has identified for the first 
time a P. aeruginosa isolate that coharbors the blaIMP-4, 
blaVIM-2, and armA antibiotic resistance genes. Although 
the XDR-PA isolates were not clonally related, the strains 
were shown to carry multiple genes encoding different 
types of movable genetic elements, which may aid the 
rapid development of XDR-PA isolates.
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